Jiang, Simon H., Mercan, Sevcan, Papa, Ilenia, Moldovan, Max, Walters, Giles D., Koina, Mark, Fadia, Mitali, Stanley, Maurice, Lea-Henry, Tom, Cook, Amelia, Ellyard, Julia, McMorran, Brendan, Sundaram, Madhivanan, Thomson, Russell, Canete, Pablo F., Hoy, Wendy, Hutton, Holly, Srivastava, Monika, McKeon, Kathryn, de la Ru´a Figueroa, In˜igo, Cervera, Ricard, Faria, Raquel, D'Alfonso, Sandra, Gatto, Mariele, Athanasopoulos, Vicki, Field, Matthew, Mathews, John, Cho, Eun, Andrews, Thomas D., Kitching, A. Richard, Cook, Matthew C., Alarcon Riquelme, Marta, Bahlo, Melanie, and Vinuesa, Carola G. (2021) Deletions in VANGL1 are a risk factor for antibody-mediated kidney disease. Cell Reports Medicine, 2. 100475.

Raspin, Kelsie, FitzGerald, Liesel M., Marthick, James R., Field, Matt A., Malley, Roslyn C., Banks, Annette, Donovan, Shaun, Thomson, Russell J., Foley, Georgea R., Stanford, Janet L., and Dickinson, Joanne L. (2021) A rare variant in EZH2 is associated with prostate cancer risk. International Journal of Cancer, 149 (5). pp. 1089-1099.